Verve Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERV and other ETFs, options, and stocks.

About VERV

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A.

CEO

Sekar Kathiresan

CEOSekar Kathiresan

Employees

274

Employees274

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2018

Founded2018

Employees

274

Employees274

VERV Key Statistics

Market cap

996.18M

Market cap996.18M

Price-Earnings ratio

-5.29

Price-Earnings ratio-5.29

Dividend yield

—

Dividend yield—

Average volume

3.43M

Average volume3.43M

High today

—

High today—

Low today

—

Low today—

Open price

$11.25

Open price$11.25

Volume

275.00

Volume275.00

52 Week high

$11.41

52 Week high$11.41

52 Week low

$2.86

52 Week low$2.86

Analyst ratings

88%

of 8 ratings

Buy

12.5%

Hold

87.5%

Sell

People also own

Based on the portfolios of people who own VERV. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

Intellia Therapeutics